Response to: Are we confident treating pT1a G1 lymphovascular space invasion-negative patients (with myometrial invasion) with chemoradiotherapy on the basis of p53abn?

Author(s):: Concin, N.; Matias-Guiu, X.; Creutzberg, C.L. (0000-0002-7008-4321); ESGO-ESTRO-ESP Endometrial

Published: 2021
Publication type: Article / Letter to editor

endometrial neoplasms

Date issued: 2021-06-01
Language: English
Publisher: BMJ PUBLISHING GROUP
Is part of
hdl: 1887/3278728
doi: 10.1136/ijgc-2021-002668